Juvenile myoclonic epilepsy

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 4 B, 2007, Pages 1266-1271

  Alfradique, Isabel ^a,b   Vasconcelos, Marcio Moacyr ^a,b,c,d  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b UFF ^*  (Brazil)

^c Mother Infant Department

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Diagnosis; Etiology; Juvenile myoclonic epilepsy; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CYTOCHROME P450; ETIRACETAM; GLUCURONOSYLTRANSFERASE; LAMOTRIGINE; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLONIC SEIZURE; COGNITION; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INHIBITION; DRUG SUBSTITUTION; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GRAND MAL SEIZURE; HUMAN; INCIDENCE; JUVENILE MYOCLONUS EPILEPSY; MAINTENANCE THERAPY; MENTAL DISEASE; MONOTHERAPY; MYOCLONIC JERK; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NEUROIMAGING; NEUROPATHOLOGY; ONSET AGE; PATHOGENESIS; RASH; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SPIKE WAVE; TACHYPHYLAXIS; TONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

EID: 41549143539     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2007000700036     Document Type: Review

References (34)

1. Welty TE. Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management. Paediatr Drugs 2006;8:303-310.
2. Arzimanoglou A, Guerrini R, Aicardi J. Epilepsies with predominantly myoclonic seizures. In Arzimanoglou A, Guerrini R, Aicardi J (Eds). Aicardi's epilepsy in children. Philadelphia: Lippincott Williams & Wilkins, 2004:58-80.
3. Engel J Jr. ILAE classification of epilepsy syndromes. Epilepsy Res 2006;70(Suppl 1):S5-S10.
4. Panayiotopoulos CP, Tahan R, Obeid T. Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment. Epilepsia 1991;32:672-676.
5. Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):S10-S14.
6. Mehndiratta MM, Aggarwal P. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure 2002;11:431-436.
7. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994;35:285-296.
8. Genton P, Gelisse P. Premature death in juvenile myoclonic epilepsy. Acta Neurol Scand 2001;104:125-129.
9. Figueredo R, Trevisol-Bittencourt PC, Ferro JBM. Estudo clínico-epidemiológico de pacientes com epilepsia mioclônica juvenil em Santa Catarina. Arq Neuropsiquiatr 1999;57:401-404.
10. Gardiner M. Genetics of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):S15-S20.
11. Zifkin B, Andermann E, Andermann F. Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy. Curr Opin Neurol 2005;18:147-153.
12. Vijai J, Kapoor A, Ravishankar HM, et al. Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population. Hum Genet 2003;113:461-463.
13. Turnbull J, Lohi H, Kearney JA, et al. Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 2005;14:2491-2500.
14. Delgado-Escueta AV, Perez-Gosiengfiao KB, Bai D, et al. Recent developments in the quest for myoclonic epilepsy genes. Epilepsia 2003;44(Suppl 11):S13-S26.
15. Durner M, Pal D, Greenberg D. Genetics of juvenile myoclonic epilepsy: faulty components and faulty wiring? Adv Neurol 2005;95:245-254.
16. Renganathan R, Delanty N. Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed. Postgrad Med J 2003;79:78-80.
17. Eriksson SH, Malmgren K, Nordborg C. Microdysgenesis in epilepsy. Acta Neurol Scand 2005;111:279-290.
18. Atakli D, Sözüer D, Atay T, Baybas S, Arpaci B. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998;7:63-66.
19. Sousa NAC, Sousa PS, Garzon E, Sakamoto AC, Yacubian EMT. Juvenile myoclonic epilepsy: analysis of factors implied in delayed diagnosis and prognosis after clinical and electroencephalographical characterization. J Epilepsy Clin Neurophysiol 2005;11:7-13.
20. Faught E. Clinical presentations and phenomenology of myoclonus. Epilepsia 2003;44(Suppl 11):S7-S12.
21. Pedersen SB, Petersen KA. Juvenile myoclonic epilepsy: clinical and EEG features. Acta Neurol Scand 1998;97:160-163.
22. Wirrell EC, Camfield CS, Camfield PR, Gordon KE, Dooley JM. Longterm prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47:912-918.
23. Araújo GM Filho, Pascalicchio TF, Sousa PS, Lin K, Guilhoto LMFF, Yacubian EMT. Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients. Epilepsy Behav 2007;10:437-441.
24. Hrachovy RA, Frost JD Jr. The EEG in selected generalized seizures. J Clin Neurophysiol 2006;23:312-332.
25. Sousa NAC, Sousa PS, Garzon E, Sakamoto AC, Braga NIO, Yacubian EMT. EEG recording after sleep deprivation in a series of patients with juvenile myoclonic epilepsy. Arq Neuropsiquiatr 2005;63:383-388.
26. Betting LE, Mory SB, Li LM, et al. Voxel-based morphometry in patients with idiopathic generalized epilepsies. Neuroimage 2006;32:498-502.
27. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE Treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-1120.
28. Motamedi M, Ali SM, Rahmat M. Comparison of valproic acid efficacy in familial versus sporadic cases of juvenile myoclonic epilepsy. Neurol India 2006;54:186-189.
29. Hitiris N, Brodie MJ. Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. Epilepsia 2005;46(Suppl 9):S149-S153.
30. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001;70:240-243.
31. Bergey GK. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005;46(Suppl 9):S161-S1683.
32. Verrotti A, Manco R, Marco G, Chiarelli F, Franzoni E. The treatment of juvenile myoclonic epilepsy. Expert Rev Neurother 2006;6:847-854.
33. Chakravarty A, Mukherjee A, Roy D. Observations on juvenile myoclonic epilepsy amongst ethnic Bengalees in West Bengal: an Eastern Indian State. Seizure 2007;16:134-141.
34. Sousa PS, Araújo GM Filho, Garzon E, Sakamoto AC, Yacubian EMT. Topiramate for the treatment of juvenile myoclonic epilepsy. Arq Neuropsiquiatr 2005;63:733-737.